Forskning ved Københavns Universitet - Københavns Universitet

Forside

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments. / Alstrup, Morten; Meyer, Jeppe; Schultz, Martin; Rasmussen, Line Jee Hartmann; Rasmussen, Lars Simon; Køber, Lars; Forberg, Jakob Lundager; Eugen-Olsen, Jesper; Iversen, Kasper.

I: World Journal of Surgery, Bind 43, Nr. 3, 2019, s. 780-790.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Alstrup, M, Meyer, J, Schultz, M, Rasmussen, LJH, Rasmussen, LS, Køber, L, Forberg, JL, Eugen-Olsen, J & Iversen, K 2019, 'Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments', World Journal of Surgery, bind 43, nr. 3, s. 780-790. https://doi.org/10.1007/s00268-018-4841-1

APA

Alstrup, M., Meyer, J., Schultz, M., Rasmussen, L. J. H., Rasmussen, L. S., Køber, L., ... Iversen, K. (2019). Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments. World Journal of Surgery, 43(3), 780-790. https://doi.org/10.1007/s00268-018-4841-1

Vancouver

Alstrup M, Meyer J, Schultz M, Rasmussen LJH, Rasmussen LS, Køber L o.a. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments. World Journal of Surgery. 2019;43(3):780-790. https://doi.org/10.1007/s00268-018-4841-1

Author

Alstrup, Morten ; Meyer, Jeppe ; Schultz, Martin ; Rasmussen, Line Jee Hartmann ; Rasmussen, Lars Simon ; Køber, Lars ; Forberg, Jakob Lundager ; Eugen-Olsen, Jesper ; Iversen, Kasper. / Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments. I: World Journal of Surgery. 2019 ; Bind 43, Nr. 3. s. 780-790.

Bibtex

@article{30fa92f9b045475b80e77c06219a3f05,
title = "Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments",
abstract = "BACKGROUND: Risk assessment strategies, such as using the American Society of Anesthesiologists (ASA) physical status classification, attempt to identify surgical high-risk patients. Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker reflecting overall systemic inflammation and immune activation, and it could potentially improve the identification of high-risk surgical patients.METHODS: We included patients acutely admitted to the emergency department who subsequently underwent surgery within 90 days of admission. Patients were stratified into low-risk or high-risk groups, according to ASA classification (ASAlow: ASA I-II; ASAhigh: ASA III-VI) and suPAR level, measured at admission (suPARhigh above and suPARlow below 5.5 ng/ml), respectively. Pre-specified complications were identified in national registries and electronic medical records. The association between ASA classification, suPAR level, CRP and the rate of postoperative complications was analyzed with logistic regression and Cox regression analyses, estimating odds ratios and hazard ratios (HRs).RESULTS: During 90-day follow-up from surgery, 31 (7.0{\%}) patients died and 158 (35.6{\%}) patients had postoperative complications. After adjusting for age, sex, and ASA classification, the HR for 90-day postoperative mortality was 2.5 (95{\%} CI 1.6-4.0) for every doubling of suPAR level. suPAR was significantly better than CRP at predicting mortality and all complications (P = 0.0036 and P = 0.0041, respectively). Combining ASA classification and suPAR level significantly improved prediction of mortality and the occurrence of a postoperative complication within 90 days after surgery (P < 0.0001).CONCLUSION: Measuring suPAR levels in acutely admitted patients may aid in identifying high-risk patients and improve prediction of postoperative complications.",
keywords = "Adult, Aged, Aged, 80 and over, Biomarkers/blood, C-Reactive Protein/metabolism, Female, Health Status, Humans, Male, Middle Aged, Mortality, Postoperative Complications/epidemiology, Predictive Value of Tests, Preoperative Period, Proportional Hazards Models, Receptors, Urokinase Plasminogen Activator/blood, Risk Assessment, Surgical Procedures, Operative",
author = "Morten Alstrup and Jeppe Meyer and Martin Schultz and Rasmussen, {Line Jee Hartmann} and Rasmussen, {Lars Simon} and Lars K{\o}ber and Forberg, {Jakob Lundager} and Jesper Eugen-Olsen and Kasper Iversen",
year = "2019",
doi = "10.1007/s00268-018-4841-1",
language = "English",
volume = "43",
pages = "780--790",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments

AU - Alstrup, Morten

AU - Meyer, Jeppe

AU - Schultz, Martin

AU - Rasmussen, Line Jee Hartmann

AU - Rasmussen, Lars Simon

AU - Køber, Lars

AU - Forberg, Jakob Lundager

AU - Eugen-Olsen, Jesper

AU - Iversen, Kasper

PY - 2019

Y1 - 2019

N2 - BACKGROUND: Risk assessment strategies, such as using the American Society of Anesthesiologists (ASA) physical status classification, attempt to identify surgical high-risk patients. Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker reflecting overall systemic inflammation and immune activation, and it could potentially improve the identification of high-risk surgical patients.METHODS: We included patients acutely admitted to the emergency department who subsequently underwent surgery within 90 days of admission. Patients were stratified into low-risk or high-risk groups, according to ASA classification (ASAlow: ASA I-II; ASAhigh: ASA III-VI) and suPAR level, measured at admission (suPARhigh above and suPARlow below 5.5 ng/ml), respectively. Pre-specified complications were identified in national registries and electronic medical records. The association between ASA classification, suPAR level, CRP and the rate of postoperative complications was analyzed with logistic regression and Cox regression analyses, estimating odds ratios and hazard ratios (HRs).RESULTS: During 90-day follow-up from surgery, 31 (7.0%) patients died and 158 (35.6%) patients had postoperative complications. After adjusting for age, sex, and ASA classification, the HR for 90-day postoperative mortality was 2.5 (95% CI 1.6-4.0) for every doubling of suPAR level. suPAR was significantly better than CRP at predicting mortality and all complications (P = 0.0036 and P = 0.0041, respectively). Combining ASA classification and suPAR level significantly improved prediction of mortality and the occurrence of a postoperative complication within 90 days after surgery (P < 0.0001).CONCLUSION: Measuring suPAR levels in acutely admitted patients may aid in identifying high-risk patients and improve prediction of postoperative complications.

AB - BACKGROUND: Risk assessment strategies, such as using the American Society of Anesthesiologists (ASA) physical status classification, attempt to identify surgical high-risk patients. Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker reflecting overall systemic inflammation and immune activation, and it could potentially improve the identification of high-risk surgical patients.METHODS: We included patients acutely admitted to the emergency department who subsequently underwent surgery within 90 days of admission. Patients were stratified into low-risk or high-risk groups, according to ASA classification (ASAlow: ASA I-II; ASAhigh: ASA III-VI) and suPAR level, measured at admission (suPARhigh above and suPARlow below 5.5 ng/ml), respectively. Pre-specified complications were identified in national registries and electronic medical records. The association between ASA classification, suPAR level, CRP and the rate of postoperative complications was analyzed with logistic regression and Cox regression analyses, estimating odds ratios and hazard ratios (HRs).RESULTS: During 90-day follow-up from surgery, 31 (7.0%) patients died and 158 (35.6%) patients had postoperative complications. After adjusting for age, sex, and ASA classification, the HR for 90-day postoperative mortality was 2.5 (95% CI 1.6-4.0) for every doubling of suPAR level. suPAR was significantly better than CRP at predicting mortality and all complications (P = 0.0036 and P = 0.0041, respectively). Combining ASA classification and suPAR level significantly improved prediction of mortality and the occurrence of a postoperative complication within 90 days after surgery (P < 0.0001).CONCLUSION: Measuring suPAR levels in acutely admitted patients may aid in identifying high-risk patients and improve prediction of postoperative complications.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Biomarkers/blood

KW - C-Reactive Protein/metabolism

KW - Female

KW - Health Status

KW - Humans

KW - Male

KW - Middle Aged

KW - Mortality

KW - Postoperative Complications/epidemiology

KW - Predictive Value of Tests

KW - Preoperative Period

KW - Proportional Hazards Models

KW - Receptors, Urokinase Plasminogen Activator/blood

KW - Risk Assessment

KW - Surgical Procedures, Operative

U2 - 10.1007/s00268-018-4841-1

DO - 10.1007/s00268-018-4841-1

M3 - Journal article

C2 - 30390135

VL - 43

SP - 780

EP - 790

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 3

ER -

ID: 233590365